Methods for treating interleukin-1 mediated diseases

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 31/00 (2006.01) A61K 38/00 (2006.01) A61K 38/20 (2006.01) C07K 14/545 (2006.01) C07K 14/715 (2006.01) C07K 16/24 (2006.01) C12P 21/02 (2006.01)

Patent

CA 2039458

73605-14 Abstract of the Invention Disclosed are medicines for treating interleukin-1 mediated diseases including interleukin-1 mediated arthritis, interleukin-1 mediated inflammatory bowel disease, interleukin-1 mediated septic shock, interleukin-1 mediated ischemia injury, and interleukin-1 mediated reperfusion injury. The medicine com- prises a therapeutically effective amount of an interleukin-1 inhibitor. In a preferred embodiment, the interleukin inhibitor is selected from the group consisting of IL-lraa, IL-lraB, IL-lrax, and a combination thereof. A preferred method of produc- ing IL-lraa, IL-lraB, Il-lrax is by recombinant DNA technology.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods for treating interleukin-1 mediated diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for treating interleukin-1 mediated diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating interleukin-1 mediated diseases will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1868537

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.